Resources for You
National Diabetes Education Program
- National Institute of Diabetes, Digestive and Kidney Diseases
- Healthfinder Diabetes Resource
- National Library of Medicine Diabetes Page
Women and Diabetes Cardiovascular Information MedWatch: The FDA Safety Information and Adverse Event Reporting Program
- Report a Serious Medical Product Problem Online
Safe Disposal of Sharps
- What do you do with used needles and other sharps?
- Diabetes researchers are working on an artificial pancreas
Insulin pens are not for sharing
- FDA consumer update on insulin pens
On these pages, expect to find diabetes-related information tailored to patients with Type 1 and Type 2 diabetes, with links to FDA web pages and other trusted government web sites. FDA is committed to getting accurate, science-based information in the hands of people with diabetes so they can use foods, medicines, and devices to maintain and improve their health. With the incidence of diabetes skyrocketing, it is important to FDA that we do what we can to inform patients.
Diabetes is the seventh leading cause of death in the United States. An estimated 25.8 million people in the U.S.—approximately 8.3% of the population—have diabetes. (What is Diabetes?)
Subscribe to FDA Updates
E-mail lists managed by GovDelivery
- FDA Diabetes Monitor - FDA's Diabetes e-mail list delivers updates on safety and regulatory issues related to diabetes, including product approvals, safety warnings, notices of upcoming public meetings, and notices about proposed regulatory guidances.
- Patient Network News - A twice monthly newsletter containing FDA-related information on a variety of topics, including new product approvals, significant labeling changes, safety warnings, public meetings, and more.
- MedWatch E-list - Clinically important medical product safety alerts, delivered via e-mail and/or SMS text messages.
The following FDA websites can help guide your search for medicines and devices.
- Division of Small Manufacturers, International and Consumer Assistance (DSMICA)can assist with questions on a variety of medical device topics.
- Division of Drug Information (DDI) is the FDA focal point for public inquiries regarding human drug products.
FDA alerts companies to stop illegal sale of treatments for diabetes FDA approves three new drug treatments for type 2 diabetes
- FDA Drug Safety Communication: Podcast: FDA investigating reports of possible increased risk of pancreatitis and pre-cancerous findings of the pancreas from incretin mimetic drugs for type 2 diabetes (MP3 - 4.1MB)
FDA Webinar: Home Use of Diabetes and Cardiovascular Medical Devices Nova Max Glucose Test Strips: Recall - May Report False, Abnormally High Blood Glucose Result